I am Dr Rajeswaran, an Endocrinologist and Diabetologist. Today, I would like to discuss a critical but often overlooked condition that I am observing in my clinical practice: Sarcopenic Obesity in Indian Adults with Type 2 Diabetes. 

Sarcopenic obesity represents a complex dual metabolic challenge that combines two distinct conditions. Sarcopenia refers to the age-related progressive loss of skeletal muscle mass and function, while obesity is the excessive accumulation of adipose tissue. When these conditions co-exist, we encounter a particularly dangerous metabolic scenario, especially for patients already managing Type 2 Diabetes. 

What makes this condition particularly insidious is its presentation. Many of my patients appear overweight or obese, but beneath this appearance lies significant muscle depletion. 

In my practice, I often see normal-weight or slightly overweight patients with diabetes who say, Doctor, I am not obese because my BMI is normal. But when we do body composition, we find high fat mass and low muscle mass. 

This is common in Indians because:

• We tend to have more visceral fat even at lower BMIs.
• We often have a sedentary lifestyle with minimal resistance training. 
• Our diets are typically high in carbohydrates and low in protein. 
  
  

All these factors are responsible for sarcopenia obesity. 

The pathophysiology connecting sarcopenic obesity and type 2 diabetes creates a detrimental cycle. Insulin resistance impairs protein synthesis and promotes muscle catabolism. Meanwhile, the chronic low-grade inflammation associated with visceral obesity further accelerates muscle degradation. 

This cycle is particularly aggressive in our Indian patients. The elevated levels of inflammatory cytokines like TNF-alpha and IL-6 that we regularly document in their blood work directly interfere with muscle anabolic pathways and insulin signalling. The concerning part is that muscle tissue serves as the primary site for glucose disposal. As muscle mass decreases, glucose tolerance worsens, creating a vicious cycle that accelerates both Diabetic complications and functional decline. 

The clinical consequences of sarcopenic obesity extend far beyond poor glycaemic control; affected patient shows:

• Accelerated development of micro- and macrovascular complications. 
• Significantly reduced functional capacity with the earlier onset of disability. 
• Decreased effectiveness of conventional antidiabetic therapies.
• Higher cardiovascular risk profiles despite similar BMI measurements.
   

The therapeutic approach to sarcopenic obesity requires addressing both conditions simultaneously. This necessitates moving beyond traditional weight-centric approaches to diabetes management. 

You can follow these

Resistance training exercises at least three times weekly, focusing on the major muscle groups. 

Have a higher protein intake of 1.2-1.5g/kg, with particular attention to leucine-rich protein sources. 

Consult your doctor and get prescribed antidiabetic medications that don’t increase your muscle loss. 

Vitamin D supplementation is necessary as deficiency is very common.


Top obesity clinic in chennai